These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37231214)

  • 1. Antiviral and protective effect of small interfering RNAs against rift valley fever virus in vitro.
    Ahmed EM; Boseila AA; Hanora AS; Solyman SM
    Mol Biol Rep; 2023 Jul; 50(7):5837-5848. PubMed ID: 37231214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cathelicidin, LL-37 a potential antiviral therapeutic for Rift Valley Fever Virus in Egypt.
    Ahmed EM; Boseila AA; Hanora AS; Solyman SM
    Cell Mol Biol (Noisy-le-grand); 2024 Sep; 70(8):1-9. PubMed ID: 39262269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells.
    Faburay B; Richt JA
    Front Microbiol; 2016; 7():1889. PubMed ID: 27933051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    Bamia A; Marcato V; Boissière M; Mansuroglu Z; Tamietti C; Romani M; Simon D; Tian G; Niedergang F; Panthier JJ; Flamand M; Souès S; Bonnefoy E
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33087469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Host Factors for Rift Valley Fever Phlebovirus.
    Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.
    Kainulainen M; Lau S; Samuel CE; Hornung V; Weber F
    J Virol; 2016 Jul; 90(13):6140-7. PubMed ID: 27122577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK1 and PP1 regulate Rift Valley fever virus genome replication through L protein phosphorylation.
    Bracci N; Baer A; Flor R; Petraccione K; Stocker T; Zhou W; Ammosova T; Dinglasan RR; Nekhai S; Kehn-Hall K
    Antiviral Res; 2024 Jun; 226():105895. PubMed ID: 38679165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection.
    Harmon B; Bird SW; Schudel BR; Hatch AV; Rasley A; Negrete OA
    J Virol; 2016 Aug; 90(16):7084-7097. PubMed ID: 27226375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Phosphatase-1 regulates Rift Valley fever virus replication.
    Baer A; Shafagati N; Benedict A; Ammosova T; Ivanov A; Hakami RM; Terasaki K; Makino S; Nekhai S; Kehn-Hall K
    Antiviral Res; 2016 Mar; 127():79-89. PubMed ID: 26801627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Limpy Skin disease viruses.
    Safini N; Bamouh Z; Hamdi J; Jazouli M; Tadlaoui KO; El Harrak M
    Sci Rep; 2021 Jun; 11(1):12395. PubMed ID: 34117312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.
    Garcia S; Crance JM; Billecocq A; Peinnequin A; Jouan A; Bouloy M; Garin D
    J Clin Microbiol; 2001 Dec; 39(12):4456-61. PubMed ID: 11724861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Evaluation of Anti-Rift Valley Fever Virus, Antioxidant and Anti-Inflammatory Activity of South African Medicinal Plant Extracts.
    More GK; Makola RT; Prinsloo G
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33572659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs.
    Scott T; Paweska JT; Arbuthnot P; Weinberg MS
    Antivir Ther; 2012; 17(4):643-56. PubMed ID: 22345363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    Brahms A; Mudhasani R; Pinkham C; Kota K; Nasar F; Zamani R; Bavari S; Kehn-Hall K
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Interference Restricts Rift Valley Fever Virus in Multiple Insect Systems.
    Dietrich I; Jansen S; Fall G; Lorenzen S; Rudolf M; Huber K; Heitmann A; Schicht S; Ndiaye EH; Watson M; Castelli I; Brennan B; Elliott RM; Diallo M; Sall AA; Failloux AB; Schnettler E; Kohl A; Becker SC
    mSphere; 2017; 2(3):. PubMed ID: 28497117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
    Tercero B; Narayanan K; Terasaki K; Makino S
    J Virol; 2021 Jun; 95(14):e0042921. PubMed ID: 33952635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus.
    Tercero B; Terasaki K; Nakagawa K; Narayanan K; Makino S
    J Virol Methods; 2019 Oct; 272():113701. PubMed ID: 31315022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.
    Ikegami T; Narayanan K; Won S; Kamitani W; Peters CJ; Makino S
    PLoS Pathog; 2009 Feb; 5(2):e1000287. PubMed ID: 19197350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
    Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.